Medicating patients during extracorporeal membrane oxygenation: the evidence is building

Amy L Dzierba; Darryl Abrams; Daniel Brodie

doi:10.1186/s13054-017-1644-y

Medicating patients during extracorporeal membrane oxygenation: the evidence is building

Crit Care. 2017 Mar 21;21(1):66. doi: 10.1186/s13054-017-1644-y.

Authors

Amy L Dzierba¹, Darryl Abrams², Daniel Brodie²

Affiliations

¹ Columbia University Medical Center, Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY, 10032, USA. ald9012@nyp.org.
² Division of Pulmonary, Columbia University College of Physicians and Surgeons, Allergy and Critical Care, 622 West 168th Street, New York, NY, 10032, USA.

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2017. Other selected articles can be found online at http://ccforum.com/series/annualupdate2017 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Analgesics / pharmacokinetics
Anti-Infective Agents / pharmacokinetics
Critical Illness / therapy*
Extracorporeal Membrane Oxygenation*
Humans
Hypnotics and Sedatives / pharmacokinetics
Pharmacokinetics*

Substances

Analgesics
Anti-Infective Agents
Hypnotics and Sedatives